CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- 4 Planned sale Chief Development Officer sold 10,115 shares at $29.99 ($303,355)
- 144 Insider Sale of Securities
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Operating Officer sold 2,014 shares at $28.93 ($58,265)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 10,916 shares at an average $29.35 ($320,373)
- 4 Planned sale Chief Scientific Officer sold 8,500 shares at an average $29.02 ($246,655)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Executive Officer sold 10,916 shares at an average $26.11 ($285,071)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Scientific Officer sold 8,500 shares at an average $26.84 ($228,132)
Page 5 of 13 · 253 filings